The Full Wiki

B-cell activating factor: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Tumor necrosis factor (ligand) superfamily, member 13b

PDB rendering based on 1jh5.
Available structures
1jh5, 1kd7, 1kxg, 1oqd, 1oqe, 1osg, 1otz
External IDs OMIM603969 MGI1344376 HomoloGene48443 GeneCards: TNFSF13B Gene
Species Human Mouse
Entrez 10673 24099
Ensembl ENSG00000102524 ENSMUSG00000031497
UniProt Q9Y275 Q3KP92
RefSeq (mRNA) NM_006573 NM_033622
RefSeq (protein) NP_006564 NP_296371
Location (UCSC) Chr 13:
107.72 - 107.76 Mb
Chr 8:
10.01 - 10.04 Mb
PubMed search [1] [2]

B-cell activating factor (BAFF) also known as tumor necrosis factor ligand superfamily member 13B is a protein that in humans is encoded by the TNFLSF13B gene.[1][2] BAFF is also known as B Lymphocyte Stimulator (BLyS) and TNF- and APOL-related leukocyte expressed ligand (TALL-1) and the Dendritic cell-derived TNF-like molecule (CD257 antigen; cluster of differentiation 257).


Structure and function

BAFF is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells.[3]

BAFF is a 285-amino acid long peptide glycoprotein which undergoes glycosylation at residue 124. It is expressed as transmembrane protein on various cell types including monocytes, dendritic cells and bone marrow stromal cells. The transmembrane form can be cleaved from the membrane, generating a soluble protein fragment. BAFF is the natural ligand of three unusual tumor necrosis factor receptors named BAFF-R, TACI, and BCMA, all of which have differing binding affinities for it. These receptors are expressed mainly on mature B lymphocytes (TACI is also found on a subset of T-cells and BCMA on plasma cells). TACI binds worst since its affinity is higher for a protein similar to BAFF, called A Proliferation Inducing Ligand (APRIL). BCMA displays an intermediate binding phenotype and will work with either BAFF or APRIL to varying degrees. Signaling through BAFF-R and BCMA stimulates B lymphocytes to undergo proliferation and to counter apoptosis. All these ligands act as heterotrimers (i.e. three of the same molecule) interacting with heterotrimeric receptors[4], although BAFF has been known to be active as either a hetero- or homotrimer.[5]


B-cell activating factor has been shown to interact with TNFRSF13B,[6][7] TNFSF13[8] and TNFRSF17.[9][10]

Clinical significance

Belimumab (Benlysta) is a monoclonal antibody developed by Human Genome Sciences that specifically recognizes and inhibits the biological activity of B-Lymphocyte stimulator (BLyS) and is in clinical trials for treatment of Systemic lupus erythematosus and other auto-immune diseases.


  1. ^ Shu HB, Hu WH, Johnson H (May 1999). "TALL-1 is a novel member of the TNF family that is down-regulated by mitogens". J. Leukoc. Biol. 65 (5): 680–3. PMID 10331498.  
  2. ^ Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J (June 1999). "BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth". J. Exp. Med. 189 (11): 1747–56. PMID 10359578.  
  3. ^ "Entrez Gene: tumor necrosis factor (ligand) superfamily".  
  4. ^ Oren,D.A., Li,Y., Volovik,Y., Morris,T.S., Dharia,C., Das,K., Galperina,O., Gentz,R. and Arnold,E. (2002). "Structural basis of BLyS receptor recognition". Nat. Struct. Biol. 9: 288–292. doi:10.1038/nsb769. PMID 11862220.  
  5. ^ Daridon C, Youinou P, Pers JO (February 2008). "BAFF, APRIL, TWE-PRIL: who's who?". Autoimmun Rev 7 (4): 267–71. doi:10.1016/j.autrev.2007.05.002. PMID 18295728.  
  6. ^ Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, Gan Y, Cho YH, Garcia AD, Gollatz E, Dimke D, LaFleur D, Migone TS, Nardelli B, Wei P, Ruben SM, Ullrich SJ, Olsen HS, Kanakaraj P, Moore PA, Baker KP (November 2000). "Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS". J. Biol. Chem. 275 (45): 35478–85. doi:10.1074/jbc.M005224200. PMID 10956646.  
  7. ^ Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovyev I, Lee F, McCabe S, Elliott R, Miner K, Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ, Hsu H (July 2000). "TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation". J. Exp. Med. 192 (1): 137–43. PMID 10880535.  
  8. ^ Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V, Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS (October 2002). "BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases". J. Immunol. 169 (8): 4314–21. PMID 12370363.  
  9. ^ Liu Y, Hong X, Kappler J, Jiang L, Zhang R, Xu L, Pan CH, Martin WE, Murphy RC, Shu HB, Dai S, Zhang G (May 2003). "Ligand-receptor binding revealed by the TNF family member TALL-1". Nature 423 (6935): 49–56. doi:10.1038/nature01543. PMID 12721620.  
  10. ^ Shu HB, Johnson H (August 2000). "B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1". Proc. Natl. Acad. Sci. U.S.A. 97 (16): 9156–61. doi:10.1073/pnas.160213497. PMID 10908663.  

Further reading

  • Nardelli B, Moore PA, Li Y, Hilbert DM (2003). "B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.". Leuk. Lymphoma 43 (7): 1367–73. doi:10.1080/10428190290033297. PMID 12389615.  
  • Zhou T, Zhang J, Carter R, Kimberly R (2003). "BLyS and B cell autoimmunity.". Curr. Dir. Autoimmun. 6: 21–37. doi:10.1159/000066854. PMID 12408045.  
  • Stohl W (2005). "A therapeutic role for BLyS antagonists.". Lupus 13 (5): 317–22. doi:10.1191/0961203304lu1019oa. PMID 15230285.  
  • Quartuccio L, Fabris M, Ferraccioli G (2004). "[B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis]". Reumatismo 56 (3): 143–6. PMID 15470519.  
  • Sutherland AP, Mackay F, Mackay CR (2007). "Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.". Pharmacol. Ther. 112 (3): 774–86. doi:10.1016/j.pharmthera.2006.06.002. PMID 16863659.  
  • Bossen C, Schneider P (2007). "BAFF, APRIL and their receptors: structure, function and signaling.". Semin. Immunol. 18 (5): 263–75. doi:10.1016/j.smim.2006.04.006. PMID 16914324.  
  • Brink R (2007). "Regulation of B cell self-tolerance by BAFF.". Semin. Immunol. 18 (5): 276–83. doi:10.1016/j.smim.2006.04.003. PMID 16916609.  
  • Tangye SG, Bryant VL, Cuss AK, Good KL (2007). "BAFF, APRIL and human B cell disorders.". Semin. Immunol. 18 (5): 305–17. doi:10.1016/j.smim.2006.04.004. PMID 16916610.  
  • Treml LS, Crowley JE, Cancro MP (2007). "BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.". Semin. Immunol. 18 (5): 297–304. doi:10.1016/j.smim.2006.07.001. PMID 16919470.  
  • Woodland RT, Schmidt MR, Thompson CB (2007). "BLyS and B cell homeostasis.". Semin. Immunol. 18 (5): 318–26. doi:10.1016/j.smim.2006.06.001. PMID 16931037.  
  • Kalled SL (2007). "Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production.". Semin. Immunol. 18 (5): 290–6. doi:10.1016/j.smim.2006.06.002. PMID 16931038.  
  • Mackay F, Leung H (2007). "The role of the BAFF/APRIL system on T cell function.". Semin. Immunol. 18 (5): 284–9. doi:10.1016/j.smim.2006.04.005. PMID 16931039.  
  • Bosello S, Pers JO, Rochas C, et al. (2007). "BAFF and rheumatic autoimmune disorders: implications for disease management and therapy.". International journal of immunopathology and pharmacology 20 (1): 1–8. PMID 17346422.  
  • Mukhopadhyay A, Ni J, Zhai Y, et al. (1999). "Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase.". J. Biol. Chem. 274 (23): 15978–81. doi:10.1074/jbc.274.23.15978. PMID 10347144.  
  • Moore PA, Belvedere O, Orr A, et al. (1999). "BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.". Science 285 (5425): 260–3. doi:10.1126/science.285.5425.260. PMID 10398604.  
  • Tribouley C, Wallroth M, Chan V, et al. (2000). "Characterization of a new member of the TNF family expressed on antigen presenting cells.". Biol. Chem. 380 (12): 1443–7. doi:10.1515/BC.1999.186. PMID 10661873.  
  • Gross JA, Johnston J, Mudri S, et al. (2000). "TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.". Nature 404 (6781): 995–9. doi:10.1038/35010115. PMID 10801128.  
  • Shu HB, Johnson H (2000). "B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1.". Proc. Natl. Acad. Sci. U.S.A. 97 (16): 9156–61. doi:10.1073/pnas.160213497. PMID 10908663.  

External links



Got something to say? Make a comment.
Your name
Your email address